or
forgot password
  • cancer clinical trials in seneca, SC

  • Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    Cancer Center of the Carolinas, Seneca
    Seneca, South Carolina 29672
    Metastatic Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Lung Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Leukemia
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Esophageal Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Lung Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Endometrial Cancer, Fatigue, Neurotoxicity
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Brain and Central Nervous System Tumors
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Brain and Central Nervous System Tumors
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Dinaciclib in Treating Patients With Stage IV Melanoma
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Mucosal Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Ovarian Cancer, Sarcoma
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Melanoma (Skin)
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Brain and Central Nervous System Tumors, Neurotoxicity
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Colorectal Cancer, Precancerous Condition
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Cancer Center of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Multiple Myeloma
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Kidney Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Colorectal Neoplasms
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Lymphoma
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Arthralgia, Breast Cancer, Pain
    Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
    Cancer Centers of the Carolinas - Seneca
    Seneca, South Carolina 29672
    Breast Cancer